HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: Influence of manual- and laser microdissection

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Moelans, Cathy B ^a   de Weger, Roel A ^a   Ezendam, Chantal ^a   van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ACCURACY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DUPLICATION; GENE IDENTIFICATION; GENE NUMBER; GENE OVEREXPRESSION; GENE PROBE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; LASER MICRODISSECTION; MICRODISSECTION; PROGNOSIS; SCORING SYSTEM; BIOSYNTHESIS; BREAST TUMOR; DNA PROBE; ENZYMOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENETICS; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; PROTO ONCOGENE;

BREAST NEOPLASMS; DNA PROBES; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MICRODISSECTION; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RECEPTOR, ERBB-2;

EID: 59249106279     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-4     Document Type: Article

References (23)

1. Akiyama T Sudo C Ogawara H Toyoshima K Yamamoto T The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity Science 1986, 232:1644-1646. 10.1126/science.3012781 3012781
2. Popescu NC King CR Kraus MH Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32 Genomics 1989, 4:362-366. 10.1016/0888-7543(89)90343-1 2565881
3. Owens MA Horten BC Da Silva MM HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues Clin Breast Cancer 2004, 5:63-69. 10.3816/CBC.2004.n.011 15140287
4. Ross JS Fletcher JA Bloom KJ Linette GP Stec J Symmans WF et al. Targeted therapy in breast cancer: The HER-2/neu gene and protein Mol Cell Proteomics 2004, 3:379-398. 10.1074/mcp.R400001-MCP200 14762215
5. Slamon DJ Godolphin W Jones LA Holt JA Wong SG Keith DE et al Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 1989, 244:707-712. 10.1126/science.2470152 2470152
6. Slamon DJ Leyland-Jones B Shak S Fuchs H Paton V Bajamonde A et al Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 2001, 344:783-792. 10.1056/NEJM200103153441101 11248153
7. Hudis CA Trastuzumab, mechanism of action and use in clinical practice N Engl J Med 2007, 357:39-51. 10.1056/NEJMra043186 17611206
8. Joensuu H Kellokumpu-Lehtinen PL Bono P Alanko T Kataja V Asola R et al Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer N Engl J Med 2006, 354:809-820. 10.1056/NEJMoa053028 16495393
9. Slamon DJ Clark GM Wong SG Levin WJ Ullrich A McGuire WL Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987, 235:177-182. 10.1126/science.3798106 3798106
10. Sjogren S Inganas M Lindgren A Holmberg L Bergh J Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers J Clin Oncol 1998, 16:462-469. 9469329
11. Borg A Baldetorp B Ferno M Killander D Olsson H Ryden S et al ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer Cancer Lett 1994, 81:137-144. 10.1016/0304-3835(94)90194-5 7912163
12. Carlomagno C Perrone F Gallo C De Laurentiis M Lauria R Morabito A et al c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases J Clin Oncol 1996, 14:2702-2708. 8874330
13. Tetu B Brisson J Plante V Bernard P p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer Mod Pathol 1998, 11:823-830. 9758361
14. Pauletti G Dandekar S Rong H Ramos L Peng H Seshadri R et al Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry J Clin Oncol 2000, 18:3651-3664. 11054438
15. Jimenez RE Wallis T Tabasczka P Visscher DW Determination of Her-2/Neu status in breast carcinoma: Comparative analysis of immunohistochemistry and fluorescent in situ hybridization Mod Pathol 2000, 13:37-45. 10.1038/ modpathol.3880007 10658908
16. Lebeau A Deimling D Kaltz C Sendelhofert A Iff A Luthardt B et al Her-2/ neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization J Clin Oncol 2001, 19:354-363. 11208826
17. Tanner M Gancberg D Di LA Larsimont D Rouas G Piccart MJ et al Chromogenic in situ hybridization: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples Am J Pathol 2000, 157:1467-1472. 1885742 11073807
18. Schouten JP McElgunn CJ Waaijer R Zwijnenburg D Diepvens F Pals G Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 2002, 30:e57. 117299 12060695 10.1093/nar/gnf056
19. Purnomosari D Aryandono T Setiaji K Nugraha SB Pals G van Diest PJ Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer Biotech Histochem 2006, 81:79-85. 10.1080/ 10520290600822198 16908432
20. Moelans CB de Weger RA van Blokland MT Ezendam C Elshof S Tilanus MG et al HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization Cell Oncol 2009, 31:1-10. 19096145
21. Murray GI An overview of laser microdissection technologies Acta Histochem 2007, 109:171-176. 10.1016/j.acthis.2007.02.001 17462720
22. Micke P Bjornsen T Scheidl S Stromberg S Demoulin JB Ponten F et al A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapulting J Pathol 2004, 202:130-138. 10.1002/path.1496 14694530
23. Bartkova J Barnes DM Millis RR Gullick WJ Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ Hum Pathol 1990, 21:1164-1167. 10.1016/0046-8177(90)90154-W 1977679